Allspring Global Investments’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,119
Closed -$735K 1805
2025
Q1
$735K Buy
13,119
+1,421
+12% +$85.1K ﹤0.01% 1342
2024
Q4
$719K Buy
11,698
+10,452
+839% +$676K ﹤0.01% 1366
2024
Q3
$83.4K Buy
1,246
+7
+0.6% +$475 ﹤0.01% 1804
2024
Q2
$82.8K Buy
+1,239
New +$84.3K ﹤0.01% 1886
2024
Q1
Sell
-3
Closed -$252 2404
2023
Q4
$252 Sell
3
-607
-100% -$50.3K ﹤0.01% 2191
2023
Q3
$52.5K Sell
610
-310
-34% -$28.6K ﹤0.01% 2252
2023
Q2
$85.7K Sell
920
-71
-7% -$6.69K ﹤0.01% 2113
2023
Q1
$93.9K Buy
991
+99
+11% +$9.1K ﹤0.01% 2076
2022
Q4
$89.7K Sell
892
-19
-2% -$1.73K ﹤0.01% 2116
2022
Q3
$77K Sell
911
-649
-42% -$57.3K ﹤0.01% 2181
2022
Q2
$134K Sell
1,560
-4,245
-73% -$362K ﹤0.01% 1959
2022
Q1
$521K Sell
5,805
-5,061
-47% -$465K ﹤0.01% 2203
2021
Q4
$1.09M Buy
+10,866
New +$1.11M ﹤0.01% 1888

Other funds holding UTMD

Allspring Global Investments's UTMD Position: Q2 2025 in Review

Allspring Global Investments sold out of Utah Medical Products (UTMD) in Q2 2025, closing a stake of 13,119 shares — an estimated $735K sold.

Allspring Global Investments first reported a position in UTMD in Q4 2021 and held it in 13 quarters. The position peaked at $1.09M in Q4 2021. 112 funds tracked by Wall St. Rank hold UTMD as of Q2 2025.

  • Allspring Global Investments reported no remaining Utah Medical Products position as of Q2 2025 after selling out during the quarter.
  • Allspring Global Investments sold 13,119 Utah Medical Products shares in Q2 2025, an estimated $735K.
  • Allspring Global Investments first reported a position in Utah Medical Products in Q4 2021 and held it in 13 quarters.
  • Allspring Global Investments's Utah Medical Products position peaked at $1.09M in Q4 2021.
  • 112 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2025.

Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.